Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
bone1 (58) 58
humans (58) 58
life sciences & biomedicine (53) 53
oncology (53) 53
science & technology (53) 53
original reports (52) 52
female (51) 51
male (51) 51
middle aged (47) 47
adult (44) 44
biological and medical sciences (40) 40
medical sciences (40) 40
tumors (40) 40
aged (39) 39
treatment outcome (31) 31
young adult (25) 25
hematologic and hematopoietic diseases (24) 24
adolescent (23) 23
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (23) 23
bone2 (22) 22
transplantation, homologous (20) 20
child (15) 15
hematopoietic stem cell transplantation (14) 14
survival analysis (14) 14
disease-free survival (13) 13
hematopoietic stem cell transplantation - adverse effects (13) 13
prognosis (13) 13
retrospective studies (13) 13
child, preschool (12) 12
bone5 (11) 11
kaplan-meier estimate (11) 11
aged, 80 and over (10) 10
hematopoietic stem cell transplantation - methods (10) 10
risk factors (10) 10
survival rate (10) 10
transplantation conditioning - methods (10) 10
cohort studies (9) 9
remission induction (9) 9
age factors (8) 8
graft vs host disease - prevention & control (8) 8
proportional hazards models (8) 8
risk assessment (8) 8
time factors (8) 8
transplantation conditioning (8) 8
graft vs host disease - etiology (7) 7
hema5 (7) 7
hematologic neoplasms - therapy (7) 7
multivariate analysis (7) 7
recurrence (7) 7
bone4 (6) 6
disease progression (6) 6
follow-up studies (6) 6
graft vs host disease - diagnosis (6) 6
hema7 (6) 6
leukemia, myeloid, acute - surgery (6) 6
to19 (6) 6
unrelated donors (6) 6
bios4 (5) 5
hema9 (5) 5
infant (5) 5
leukemia, myeloid, acute - mortality (5) 5
leukemia, myeloid, acute - therapy (5) 5
medicin och hälsovetenskap (5) 5
myelodysplastic syndromes - therapy (5) 5
neoplasm staging (5) 5
precursor cell lymphoblastic leukemia-lymphoma - mortality (5) 5
psc12 (5) 5
survivors (5) 5
tissue donors (5) 5
bios3 (4) 4
cmpl4 (4) 4
drug administration schedule (4) 4
graft vs host disease - mortality (4) 4
hematologic neoplasms - mortality (4) 4
hematopoietic stem cell transplantation - mortality (4) 4
mutation (4) 4
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (4) 4
precursor cell lymphoblastic leukemia-lymphoma - surgery (4) 4
prospective studies (4) 4
psc13 (4) 4
severity of illness index (4) 4
to2 (4) 4
to6 (4) 4
united states (4) 4
acute disease (3) 3
analysis of variance (3) 3
antineoplastic agents - therapeutic use (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
bone marrow transplantation - methods (3) 3
cancer (3) 3
cause of death (3) 3
dose-response relationship, drug (3) 3
graft rejection (3) 3
hema11 (3) 3
hema6 (3) 3
hema8 (3) 3
hemic and lymphatic diseases (3) 3
immunosuppressive agents - therapeutic use (3) 3
leukemia, myelogenous, chronic, bcr-abl positive - mortality (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Allogeneic hematopoietic cell transplantation for acute myeloid leukemia: Time to move toward a minimal residual disease-based definition of complete remission?
by Araki, Daisuke and Wood, Brent L and Othus, Megan and Radich, Jerald P and Halpern, Anna B and Zhou, Yi and Mielcarek, Marco and Estey, Elihu H and Appelbaum, Frederick R and Walter, Roland B
Journal of clinical oncology, ISSN 0732-183X, 02/2016, Volume 34, Issue 4, pp. 329 - 336
Life Sciences & Biomedicine | Oncology | Science & Technology | Leukemia, Myeloid, Acute - pathology | Humans | Middle Aged | Hematopoietic Stem Cell Transplantation | Male | Treatment Outcome | Remission Induction | Transplantation, Homologous | Neoplasm, Residual | Young Adult | Adult | Female | Aged | Retrospective Studies | Leukemia, Myeloid, Acute - therapy | Index Medicus | ORIGINAL REPORTS | Bone1
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Allogeneic T cells that express an anti-CD19 chimeric antigen receptor induce remissions of B-cell malignancies that progress after allogeneic hematopoietic stem-cell transplantation without causing graft-versus-host disease
by Brudno, Jennifer N and Somerville, Robert P.T and Shi, Victoria and Rose, Jeremy J and Halverson, David C and Fowler, Daniel H and Gea-Banacloche, Juan C and Pavletic, Steven Z and Hickstein, Dennis D and Lu, Tangying L and Feldman, Steven A and Iwamoto, Alexander T and Kurlander, Roger and Maric, Irina and Goy, Andre and Hansen, Brenna G and Wilder, Jennifer S and Blacklock-Schuver, Bazetta and Hakim, Frances T and Rosenberg, Steven A and Gress, Ronald E and Kochenderfer, James N
Journal of clinical oncology, ISSN 0732-183X, 04/2016, Volume 34, Issue 10, pp. 1112 - 1121
Life Sciences & Biomedicine | Oncology | Science & Technology | Leukemia, Lymphocytic, Chronic, B-Cell - surgery | Receptors, Antigen, T-Cell - metabolism | Humans | Middle Aged | Male | Remission Induction | Transplantation Chimera | Disease Progression | T-Lymphocytes - transplantation | Transplantation, Homologous | Leukemia, B-Cell - surgery | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | T-Lymphocytes - immunology | Aged | Leukemia, B-Cell - immunology | Graft vs Host Disease - etiology | Leukemia, Lymphocytic, Chronic, B-Cell - immunology | Antigens, CD19 - immunology | Index Medicus | Hema7 | Bone2 | Hema15 | To6 | Bone1 | ORIGINAL REPORTS
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation
by Bejar, Rafael and Stevenson, Kristen E and Caughey, Bennett and Lindsley, R. Coleman and Mar, Brenton G and Stojanov, Petar and Getz, Gad and Steensma, David P and Ritz, Jerome and Soiffer, Robert and Antin, Joseph H and Alyea, Edwin and Armand, Philippe and Ho, Vincent and Koreth, John and Neuberg, Donna and Cutler, Corey S and Ebert, Benjamin L
Journal of clinical oncology, ISSN 0732-183X, 09/2014, Volume 32, Issue 25, pp. 2691 - 2698
Life Sciences & Biomedicine | Oncology | Science & Technology | Prognosis | Humans | Middle Aged | Male | Transplantation, Autologous | Treatment Outcome | Young Adult | Disease-Free Survival | Myelodysplastic Syndromes - therapy | Adult | Female | Aged | Myelodysplastic Syndromes - genetics | Hematopoietic Stem Cell Transplantation - methods | Mutation | Transplantation Conditioning | Index Medicus | To19 | To2 | To13 | Bone1 | To8 | ORIGINAL REPORTS | Hema9
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Comorbidity-age index: A clinical measure of biologic age before allogeneic hematopoietic cell transplantation
by Sorror, Mohamed L and Storb, Rainer F and Sandmaier, Brenda M and Maziarz, Richard T and Pulsipher, Michael A and Maris, Michael B and Bhatia, Smita and Ostronoff, Fabiana and Deeg, H. Joachim and Syrjala, Karen L and Estey, Elihu and Maloney, David G and Appelbaum, Frederick R and Martin, Paul J and Storer, Barry E
Journal of clinical oncology, ISSN 0732-183X, 10/2014, Volume 32, Issue 29, pp. 3249 - 3256
Life Sciences & Biomedicine | Oncology | Science & Technology | Decision Making | Hematologic Neoplasms - therapy | Prognosis | Age Factors | Comorbidity | Health Status Indicators | Humans | Middle Aged | Hematopoietic Stem Cell Transplantation | Male | Treatment Outcome | Transplantation, Homologous | Adult | Female | Aged | Retrospective Studies | Index Medicus | Bone2 | Bone1 | Psc12 | ORIGINAL REPORTS | Bone5
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation
by John R. Wingard and Navneet S. Majhail and Ruta Brazauskas and Zhiwei Wang and Kathleen A. Sobocinski and David Jacobsohn and Mohamed L. Sorror and Mary M. Horowitz and Brian Bolwell and J. Douglas Rizzo and Gérard Socié
Journal of clinical oncology, ISSN 0732-183X, 06/2011, Volume 29, Issue 16, pp. 2230 - 2239
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Tumors | Graft vs Host Disease - epidemiology | Age Factors | Follow-Up Studies | Humans | Middle Aged | Risk Factors | Child, Preschool | Hematologic Diseases - surgery | Infant | Male | Hematopoietic Stem Cell Transplantation - mortality | Cause of Death | Transplantation, Homologous | Young Adult | Adolescent | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Aged | Child | Index Medicus | Bone2 | Original Reports | Bone1
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using myeloablative busulfan and fludarabine conditioning
by Kanakry, Christopher G and O'Donnell, Paul V and Furlong, Terry and De Lima, Marcos J and Wei, Wei and Medeot, Marta and Mielcarek, Marco and Champlin, Richard E and Jones, Richard J and Thall, Peter F and Andersson, Borje S and Luznik, Leo
Journal of clinical oncology, ISSN 0732-183X, 11/2014, Volume 32, Issue 31, pp. 3497 - 3505
Life Sciences & Biomedicine | Oncology | Science & Technology | Myeloablative Agonists - therapeutic use | Graft vs Host Disease - epidemiology | Busulfan - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Hematopoietic Stem Cell Transplantation | Male | Treatment Outcome | Vidarabine - analogs & derivatives | Vidarabine - therapeutic use | Cyclophosphamide - therapeutic use | Incidence | Bayes Theorem | Adult | Female | Graft vs Host Disease - prevention & control | Aged | Transplantation Conditioning - methods | Index Medicus | ORIGINAL REPORTS | Bone1
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Role of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem-Cell Transplantation in Older Patients With De Novo Myelodysplastic Syndromes: An International Collaborative Decision Analysis
by John Koreth and Joseph Pidala and Waleska S. Perez and H. Joachim Deeg and Guillermo Garcia-Manero and Luca Malcovati and Mario Cazzola and Sophie Park and Raphael Itzykson and Lionel Ades and Pierre Fenaux and Martin Jadersten and Eva Hellstrom-Lindberg and Robert Peter Gale and C.L. Beach and Stephanie J. Lee and Mary M. Horowitz and Peter L. Greenberg and Martin S. Tallman and John F. DiPersio and Donald Bunjes and Daniel J. Weisdorf and Corey Cutler
Journal of clinical oncology, ISSN 0732-183X, 07/2013, Volume 31, Issue 21, pp. 2662 - 2670
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Markov Chains | Humans | Middle Aged | Decision Support Techniques | Quality of Life | Female | Male | Aged | International Cooperation | Hematopoietic Stem Cell Transplantation - methods | Transplantation Conditioning - methods | Myelodysplastic Syndromes - surgery | Index Medicus | ORIGINAL REPORTS | Hema5 | Bone1 | Klinisk medicin | Medicin och hälsovetenskap | Kirurgi | Cancer och onkologi
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group
by Stephen P. Hunger and Xiaomin Lu and Meenakshi Devidas and Bruce M. Camitta and Paul S. Gaynon and Naomi J. Winick and Gregory H. Reaman and William L. Carroll
Journal of clinical oncology, ISSN 0732-183X, 05/2012, Volume 30, Issue 14, pp. 1663 - 1669
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Multivariate Analysis | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Age Factors | United States | Humans | Child, Preschool | National Cancer Institute (U.S.) | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Cause of Death | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Time Factors | Female | Retrospective Studies | Child | Severity of Illness Index | Risk Assessment | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Clinical Trials as Topic | Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis | Disease Progression | Disease-Free Survival | Adolescent | Sex Factors | Survival Analysis | Cohort Studies | Index Medicus | Adolescence | Acute lymphatic leukemia | Cell survival | Risk groups | Toxicity | Clinical trials | Infants | Lymphocytes T | Survival | Races | Lymphocytes B | Ethnic groups | Children | Age | ORIGINAL REPORTS | Bone4 | Bone1
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Outcomes of nonmyeloablative HLA-haploidentical blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in older adults
by Kasamon, Yvette L and Bolaños-Meade, Javier and Prince, Gabrielle T and Tsai, Hua-Ling and McCurdy, Shannon R and Kanakry, Jennifer A and Rosner, Gary L and Brodsky, Robert A and Perica, Karlo and Smith, B. Douglas and Gladstone, Douglas E and Swinnen, Lode J and Showel, Margaret M and Matsui, William H and Huff, Carol Ann and Borrello, Ivan and Pratz, Keith W and McDevitt, Michael A and Gojo, Ivana and Dezern, Amy E and Shanbhag, Satish and Levis, Mark J and Luznik, Leo and Ambinder, Richard F and Fuchs, Ephraim J and Jones, Richard J
Journal of clinical oncology, ISSN 0732-183X, 10/2015, Volume 33, Issue 28, pp. 3152 - 3161
Life Sciences & Biomedicine | Oncology | Science & Technology | Haplotypes | Hematologic Neoplasms - therapy | Recurrence | Cyclophosphamide - administration & dosage | Age Factors | Hematologic Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents, Alkylating - administration & dosage | HLA Antigens - genetics | Cyclophosphamide - adverse effects | Patient Selection | Graft vs Host Disease - mortality | Time Factors | Female | Retrospective Studies | Chemotherapy, Adjuvant | Graft vs Host Disease - diagnosis | Graft vs Host Disease - etiology | Hematologic Neoplasms - diagnosis | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | HLA Antigens - immunology | Treatment Outcome | Disease Progression | Disease-Free Survival | Bone Marrow Transplantation - mortality | Bone Marrow Transplantation - adverse effects | Aged | Hematologic Neoplasms - genetics | Hematologic Neoplasms - immunology | Tissue Donors | Transplantation Conditioning | Antineoplastic Agents, Alkylating - adverse effects | Index Medicus | Bone2 | ORIGINAL REPORTS | Bone1
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Effect of Age on Outcome of Reduced-Intensity Hematopoietic Cell Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission or With Myelodysplastic Syndrome
by Brian L. McClune and Daniel J. Weisdorf and Tanya L. Pedersen and Gisela Tunes da Silva and Martin S. Tallman and Jorge Sierra and John DiPersio and Armand Keating and Robert P. Gale and Biju George and Vikas Gupta and Theresa Hahn and Luis Isola and Madan Jagasia and Hillard Lazarus and David Marks and Richard Maziarz and Edmund K. Waller and Chris Bredeson and Sergio Giralt
Journal of clinical oncology, ISSN 0732-183X, 04/2010, Volume 28, Issue 11, pp. 1878 - 1887
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Age Factors | Leukemia, Myeloid, Acute - pathology | Humans | Middle Aged | Neoplasm Recurrence, Local - therapy | Hematopoietic Stem Cell Transplantation | Male | Survival Rate | Treatment Outcome | Remission Induction | Transplantation, Homologous | Neoplasm Recurrence, Local - pathology | Adult | Female | Aged | Transplantation Conditioning | Neoplasm Staging | Leukemia, Myeloid, Acute - therapy | Index Medicus | Original Reports | Bone1
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Biomarker panel for chronic graft-versus-host disease
by Yu, Jeffrey and Storer, Barry E and Kushekhar, Kushi and Zaid, Mohammad Abu and Zhang, Qing and Gafken, Philip R and Ogata, Yuko and Martin, Paul J and Flowers, Mary E and Hansen, John A and Arora, Mukta and Cutler, Corey and Jagasia, Madan and Pidala, Joseph and Hamilton, Betty K and Chen, George L and Pusic, Iskra and Lee, Stephanie J and Paczesny, Sophie
Journal of clinical oncology, ISSN 0732-183X, 08/2016, Volume 34, Issue 22, pp. 2583 - 2590
Life Sciences & Biomedicine | Oncology | Science & Technology | Osteopontin - blood | Prognosis | Prospective Studies | Enzyme-Linked Immunosorbent Assay | Humans | Middle Aged | Chemokine CXCL9 - blood | Hematopoietic Stem Cell Transplantation | Male | Biomarkers - blood | Time Factors | Interleukin-1 Receptor-Like 1 Protein - blood | Adult | Female | Matrix Metalloproteinase 3 - blood | Chronic Disease | Graft vs Host Disease - diagnosis | Postoperative Complications | Index Medicus | ORIGINAL REPORTS | Bone1
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights